Center for Respiratory Biology and Therapeutics
The Center for Respiratory Biology and Therapeutics brings together scientific research teams to build a transformative “bench to bedside and back” effort to drive the next phase of discoveries and novel therapeutics for pediatric respiratory diseases.
As global leaders in the creation of innovative therapies, researchers in the Center for Respiratory Biology and Therapeutics are transforming the treatment of pediatric respiratory diseases.
Next Phase Respiratory Therapeutics Powered By Research
Propelled by innovative research, our pediatric pulmonary and lung surgery program is ranked among the top ten in the nation. Pioneering virtual surgical planning techniques for complex pediatric airway and esophageal procedures, center researchers are transforming treatments for patients being seen at Seattle Children’s Airway and Esophageal Center. The center’s clinician researchers build on Seattle Children’s distinguished legacy of innovative treatments and next phase therapeutics for a wide array of pediatric respiratory diseases.
Featured Research
Through scientific collaboration and innovation, the Center for Respiratory Biology and Therapeutics aims to improve care for children with respiratory disease and train the next generation of respiratory researchers.
We’re uniting investigators with a shared purpose. The center aims to foster a collaborative environment where clinicians and basic scientists from a vast array of disciplines including community health, global health, pediatric pulmonary, sleep medicine, otolaryngology, critical care, neonatology, pathology and respiratory therapy can work in close partnership, facilitating the rapid translation of research discoveries into tangible healthcare improvements.
- Dr. Jason Debley, director for the Center for Respiratory Biology and Therapeutics
Research Areas of Focus
The Center for Respiratory Biology and Therapeutics' physician-scientists lead basic, translational, clinical, epidemiologic and global health research to develop and implement new respiratory therapies across a range of research focus areas.
- Cystic fibrosis
- Asthma
- Chronic lung disease of prematurity
- Congenital and acquired structural airway and lung diseases
- Acute and chronic respiratory failure
- Novel respiratory support technologies
- Novel technologies to deliver inhaled medications
- Sleep disordered breathing
- Primary ciliary dyskinesia
- Respiratory global health research
- Interstitial lung disease
- Pulmonary hypertension
- Respiratory quality improvement research